Summary
This prediction ended on 14.03.20 with a price of €35.65. The prediction had a final performance of 16.89%. Mori8 has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
QIAGEN NV | - | - | - | - |
iShares Core DAX® | 2.687% | -4.620% | 11.789% | 9.959% |
iShares Nasdaq 100 | 5.569% | -7.315% | 24.297% | 36.179% |
iShares Nikkei 225® | 3.756% | -7.813% | 10.017% | 3.466% |
iShares S&P 500 | 3.959% | -3.697% | 21.637% | 35.681% |
According to Mori8 what are the pros and cons of QIAGEN NV for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
ROE higher than 10% per year
Higher EBIT margin than peer group
Cons
Little Investments for future growth
Comments by Mori8 for this prediction
In the thread QIAGEN NV diskutieren
Buy mit Kursziel 38,0
Frankfurt (Reuters) - Der US-Laborausrüster Thermo Fisher schluckt das Biotechunternehmen Qiagen für 10,4 Milliarden Euro.
https://de.reuters.com/article/deutschland-qiagen-thomas-fisher-idDEKBN20Q0OC
https://de.reuters.com/article/deutschland-qiagen-thomas-fisher-idDEKBN20Q0OC
In the thread Trading QIAGEN NV
Buy beendet